Antimicrobial resistance and use, and rates of hospitalization associated with bacterial infections, including sepsis

TL;DR

This paper explores the link between antibiotic use, resistance, and the rising rates of severe bacterial infections like sepsis, analyzing epidemiological data and emphasizing the importance of resistance in public health outcomes.

Contribution

It provides a comprehensive review of evidence linking antibiotic resistance and use to sepsis hospitalizations, highlighting differences between the UK and US.

Findings

Antibiotic resistance correlates with increased sepsis hospitalizations.

Differences in antibiotic use and resistance patterns between UK and US.

Resistance to common antibiotics impacts severe bacterial infection outcomes.

Abstract

While the mechanisms and quantitative details are complex, few analysts would doubt that antibiotic use increases the prevalence of drug-resistant bacterial pathogens among all bacteria causing disease in a population. The causal connection between antibiotic use and the total incidence of severe bacterial infections, possibly mediated by antibiotic resistance, is less clearly established. The increasing burden of severe bacterial infections and their sequelae, particularly sepsis, in the United States and other countries, calls out for an explanation. In this Perspective we consider the evidence bearing on the hypothesis that prevalence of antibiotic resistance and levels of antibiotic use are important contributors to the rates of sepsis hospitalizations and other outcomes with bacterial etiology. In the process, we discuss the consequences of resistance to/use of commonly prescribed antibiotics, including fluoroquinolones, and provide a comparison of the epidemiology of antibiotic use/resistance and severe outcomes associated with infections with bacterial pathogens, particularly Escherichia coli, methicillin-resistant Staphylococcus aureus (MRSA), and Clostridium Difficile in the UK vs. US.